Curative Biotechnology, Inc. Share Price Other OTC
Equities
CTYX
US20786Q2093
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 1.35Cr 112.15Cr |
---|---|---|---|---|---|
Net income 2022 | -50L -42Cr | Net income 2023 | -30L -25Cr | EV / Sales 2022 | - |
Net Debt 2022 | 10.66L 8.88Cr | Net Debt 2023 | 22.02L 18Cr | EV / Sales 2023 | - |
P/E ratio 2022 |
-2.09
x | P/E ratio 2023 |
-2.42
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.94% |
Managers | Title | Age | Since |
---|---|---|---|
I. Garr
CEO | Chief Executive Officer | 71 | 11/21/11 |
Paul M. Michael
CHM | Chairman | - | - |
Steve Chizzik
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Cary Sucoff
BRD | Director/Board Member | 71 | 12/22/12 |
Theresa Heah
BRD | Director/Board Member | 46 | 31/03 |
Lawrence Zaslow
BRD | Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
+44.48% | 5.51TCr | |
+43.57% | 4.02TCr | |
-0.86% | 4.18TCr | |
-7.59% | 2.82TCr | |
+12.30% | 2.63TCr | |
-21.83% | 1.89TCr | |
+7.15% | 1.3TCr | |
+29.40% | 1.23TCr | |
+25.15% | 1.22TCr |